Literature DB >> 9391247

Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis.

C K Ameho1, A A Adjei, E K Harrison, K Takeshita, T Morioka, Y Arakaki, E Ito, I Suzuki, A D Kulkarni, A Kawajiri, S Yamamoto.   

Abstract

BACKGROUND: It is well established that glutamine supplemented elemental diets result in less severe intestinal damage in experimental colitis. However, few studies have examined the mode of action of glutamine in reducing intestinal damage. AIMS: To examine the effects of glutamine supplemented elemental diets on the potent inflammatory cytokines interleukin 8 (IL-8) and tumour necrosis factor alpha (TNF-alpha) in trinitrobenzene sulphonic acid (TNBS) induced colitis which presents with both acute and chronic features of ulcerative colitis.
METHODS: Sprague-Dawley rats were randomised into three dietary groups and fed 20% casein (controls), or 20% casein supplemented with either 2% glutamine (2% Gln) or 4% glutamine (4% Gln). After two weeks they received intracolonic TNBS to induce colitis.
RESULTS: Both Gln groups of rats gained more weight than the control group (p < 0.05) which had progressive weight loss. Colon weight, macroscopic, and microscopic damage scores for the Gln groups were lower than in the control group (p < 0.05). IL-8 and TNF-alpha concentrations in inflamed colonic tissues were lower in the Gln groups than in the control group (p < 0.05), and correlated well with disease severity. Bacterial translocation was lower both in incidence (p < 0.05) and in the number of colony forming units (p < 0.05) for the Gln groups, than in the control group. With respect to all indices studied, the 4% Gln group performed better than did the 2% Gln group.
CONCLUSION: Prophylactic glutamine supplementation modulates the inflammatory activities of IL-8 and TNF-alpha in TNBS induced colitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391247      PMCID: PMC1891521          DOI: 10.1136/gut.41.4.487

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Attenuation of epithelial injury in acute experimental colitis by immunomodulators.

Authors:  A Higa; G W McKnight; J L Wallace
Journal:  Eur J Pharmacol       Date:  1993-08-03       Impact factor: 4.432

2.  Leukotriene D4 participates in colonic transit disturbances induced by intracolonic administration of trinitrobenzene sulfonic acid in rats.

Authors:  L Pons; M T Droy-Lefaix; L Bueno
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

3.  Diet in the management of Crohn's disease.

Authors:  A J Levi
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

4.  Nutritional issues in pediatric inflammatory bowel disease.

Authors:  E Seidman; N LeLeiko; M Ament; W Berman; D Caplan; J Evans; S Kocoshis; A Lake; K Motil; J Sutphen
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-05       Impact factor: 2.839

5.  Harry M. Vars award. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxin.

Authors:  A E Barber; W G Jones; J P Minei; T J Fahey; L L Moldawer; J L Rayburn; E Fischer; C V Keogh; G T Shires; S F Lowry
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Jul-Aug       Impact factor: 4.016

6.  Glutamine-supplemented total parenteral nutrition improves gut immune function.

Authors:  D J Burke; J C Alverdy; E Aoys; G S Moss
Journal:  Arch Surg       Date:  1989-12

7.  Prophylactic glutamine protects the intestinal mucosa from radiation injury.

Authors:  V S Klimberg; W W Souba; D J Dolson; R M Salloum; R D Hautamaki; D A Plumley; W M Mendenhall; F J Bova; S R Khan; R L Hackett
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

8.  Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.

Authors:  M K Thomsen; C G Larsen; H K Thomsen; D Kirstein; T Skak-Nielsen; I Ahnfelt-Rønne; K Thestrup-Pedersen
Journal:  J Invest Dermatol       Date:  1991-02       Impact factor: 8.551

9.  Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis.

Authors:  J L Wallace; C M Keenan; D Gale; T S Shoupe
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

10.  Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.

Authors:  Y R Mahida; M Ceska; F Effenberger; L Kurlak; I Lindley; C J Hawkey
Journal:  Clin Sci (Lond)       Date:  1992-03       Impact factor: 6.124

View more
  78 in total

1.  LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease.

Authors:  Agnes Coste; Laurent Dubuquoy; Romain Barnouin; Jean-Sebastien Annicotte; Benjamin Magnier; Mario Notti; Nadia Corazza; Maria Cristina Antal; Daniel Metzger; Pierre Desreumaux; Thomas Brunner; Johan Auwerx; Kristina Schoonjans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

2.  Effectiveness of a hydroxynaphthoquinone fraction from Arnebia euchroma in rats with experimental colitis.

Authors:  Hua-Ying Fan; Zi-Liang Zhang; Ke Liu; Ming-Yan Yang; Wei-Hong Lv; Xin Che; Hui Xu; Wei-Wei Song
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.

Authors:  Julia Preising; David Philippe; Marita Gleinser; Hua Wei; Stephanie Blum; Bernhard J Eikmanns; Jan-Hendrik Niess; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

Review 4.  Immunonutrition in head and neck cancer: have a look before surgery!

Authors:  Chiara Bianchini; Andrea Ciorba; Francesco Stomeo; Stefano Pelucchi; Antonio Pastore
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-11       Impact factor: 2.503

5.  L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Authors:  G Fortin; K Yurchenko; C Collette; M Rubio; A-C Villani; A Bitton; M Sarfati; D Franchimont
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

6.  Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.

Authors:  T G Moreels; R J Nieuwendijk; J G De Man; B Y De Winter; A G Herman; E A Van Marck; P A Pelckmans
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage.

Authors:  Eran Israeli; Eduard Berenshtein; Dov Wengrower; Larisa Aptekar; Ron Kohen; Gershom Zajicek; Eran Goldin
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats.

Authors:  M Barbier; C Cherbut; A C Aubé; H M Blottière; J P Galmiche
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

9.  Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Authors:  Benoit Foligné; Sophie Nutten; Lothar Steidler; Véronique Dennin; Denise Goudercourt; Annick Mercenier; Bruno Pot
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

10.  A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.

Authors:  Genevieve Fortin; Marianne Raymond; Vu Quang Van; Manuel Rubio; Patrick Gautier; Marika Sarfati; Denis Franchimont
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.